Biomerica Inc (BMRA)
0.3558
-0.01
(-2.12%)
USD |
NASDAQ |
Nov 14, 16:00
0.3558
0.00 (0.00%)
After-Hours: 18:45
Biomerica Revenue (Quarterly): 1.807M for Aug. 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | 1.807M |
| May 31, 2024 | 1.116M |
| February 29, 2024 | 1.017M |
| November 30, 2023 | 1.567M |
| August 31, 2023 | 1.713M |
| May 31, 2023 | 1.108M |
| February 28, 2023 | 1.111M |
| November 30, 2022 | 1.482M |
| August 31, 2022 | 1.637M |
| May 31, 2022 | 5.302M |
| February 28, 2022 | 7.660M |
| November 30, 2021 | 4.647M |
| August 31, 2021 | 1.262M |
| May 31, 2021 | 1.054M |
| February 28, 2021 | 3.629M |
| November 30, 2020 | 1.372M |
| August 31, 2020 | 1.144M |
| May 31, 2020 | 2.725M |
| February 29, 2020 | 1.177M |
| November 30, 2019 | 1.596M |
| August 31, 2019 | 1.194M |
| May 31, 2019 | 1.166M |
| February 28, 2019 | 1.261M |
| November 30, 2018 | 1.501M |
| August 31, 2018 | 1.273M |
| Date | Value |
|---|---|
| May 31, 2018 | 1.130M |
| February 28, 2018 | 1.376M |
| November 30, 2017 | 1.614M |
| August 31, 2017 | 1.444M |
| May 31, 2017 | 1.449M |
| February 28, 2017 | 1.500M |
| November 30, 2016 | 1.432M |
| August 31, 2016 | 1.410M |
| May 31, 2016 | 1.326M |
| February 29, 2016 | 1.362M |
| November 30, 2015 | 1.165M |
| August 31, 2015 | 1.287M |
| May 31, 2015 | 1.495M |
| February 28, 2015 | 1.299M |
| November 30, 2014 | 1.134M |
| August 31, 2014 | 1.034M |
| May 31, 2014 | 1.679M |
| February 28, 2014 | 1.493M |
| November 30, 2013 | 0.9348M |
| August 31, 2013 | 1.014M |
| May 31, 2013 | 1.470M |
| February 28, 2013 | 1.417M |
| November 30, 2012 | 1.884M |
| August 31, 2012 | 1.702M |
| May 31, 2012 | 1.542M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.017M
Minimum
Feb 2024
7.660M
Maximum
Feb 2022
2.206M
Average
1.524M
Median
Revenue (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 6.029M |
| InfuSystems Holdings Inc | 35.32M |
| Xtant Medical Holdings Inc | 29.94M |
| Catheter Precision Inc | 0.093M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.316M |
| Total Expenses (Quarterly) | 3.175M |
| EPS Diluted (Quarterly) | -0.08 |
| Enterprise Value | 3.295M |
| Gross Profit Margin (Quarterly) | 15.99% |
| Profit Margin (Quarterly) | -72.83% |
| Earnings Yield | -104.0% |
| Normalized Earnings Yield | -103.99 |